Physician profile
Marshall C Spalding
NPI 1316261100
$449,711.93
in general payments reported to CMS, 2019-2025
8 companies · $251K in 2025
The $251K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,295 · 2020: $41.62 · 2021: $111 · 2022: $4,480 · 2023: $30K · 2024: $159K · 2025: $251K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $401K · Travel and Lodging: $37K · Food and Beverage: $2,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $401,125.00 |
| Travel and Lodging | $37,317.57 |
| Food and Beverage | $2,341.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prytime Medical Devices, INC. | $448,324.82 | 2019-2025 | Preboa-Pro, Er-Reboa Plus |
| Zimmer Biomet Holdings, INC. | $990.26 | 2023-2025 | Advantagerib, Ribfix Blu Advantage |
| Teleflex LLC | $208.80 | 2022-2024 | Arrow, Quikclot |
| Haemonetics Corporation | $98.36 | 2022 | |
| Humacyte Global, INC. | $38.10 | 2025 | Symvess |
| Baxter Healthcare | $21.90 | 2021 | |
| Kls-Martin L.P. | $16.74 | 2024 | |
| Intuitive Surgical, INC. | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Spalding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.